pharmaphorum

JUNE 6, 2022

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that provides patients access to medications at a lower cost. . US drug prices have soared over the last several decades, causing, at times, financial hardship for patients and their families, so Cuban says he developed MCCPDC with a simple mission – “to be the low-cost provider of medications to patients.”.

Drug Pricing 144

Drug Pricing Online Pharmacies Labelling Hospitals 144

NY Times

JUNE 5, 2022

The study was small, and experts say it needs to be replicated. But for 18 people with rectal cancer, the outcome led to “happy tears.”.

145

145

Drug Patent Watch

JUNE 7, 2022

This article was originally published by Guy Shtar, Louise Azulay, Omer Nizri, Lior Rokach & Bracha Shapira in Scientific Data volume 9, Article number: 263 under a Creative Commons Attribution…. The post CDCDB: A large and continuously updated drug combination database appeared first on DrugPatentWatch - Make Better Decisions.

119

119

Pharmaceutical Commerce

JUNE 10, 2022

Proper control of type 1 and 2 diabetes can greatly reduce the personal impact and economic burden of this pervasive public health condition. To that end, stakeholders are exploring many parallel routes to help individuals and society maintain the upper hand, as the toll of diabetes continues to skyrocket.

Diabetes 105

Diabetes 105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JUNE 10, 2022

If you work in pharma, the chances are you’re no stranger to the United States Food and Drug Administration, or FDA, which regulates pharmaceuticals. But if you’re becoming more involved with the world of digital health, as many pharma companies are these days, you may find that your old FDA knowledge isn’t much help in knowing what will be required of you.

Documentation 131

Documentation 131

Outsourcing Pharma

JUNE 7, 2022

During the upcoming BIO International Convention, experts from CerFlux, the MD Anderson Cancer Center, and Aga Khan University will weigh in with insights.

111

111

Drug Channels

JUNE 6, 2022

Time for an update to the Drug Channels Institute (DCI) annual analysis of pharmacist salaries and employment. The retail pharmacy shakeout affected 2021 pharmacist employment. We found that retail pharmacies and drugstores employed fewer pharmacists, while hospitals and outpatient centers continued to add positions. As a result, the share of pharmacists who work in non-retail practice settings reached a new high.

Hospitals 96

Hospitals Physician Offices 96

pharmaphorum

JUNE 8, 2022

Owners of an iPhone or Apple Watch have a new health feature, an app called Medications, that will help them manage and track their use of medicines. The new tool works as a component of Apple’s Health app and will let users add drugs or other health products like vitamins and supplements to a personal list – either by scanning a label or finding the product in a directory – and create custom schedules for them.

Documentation 130

Documentation Labelling 130

NY Times

JUNE 7, 2022

For some patients with metastatic tumors not significantly affected by other forms of chemotherapy, the treatment halted their cancer’s growth.

Chemotherapy 98

Chemotherapy 98

Pharma Times

JUNE 6, 2022

Enhertu reduced the risk of disease progression or death compared to chemotherapy in certain patients with metastatic breast cancer

Chemotherapy 111

Chemotherapy 111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Channels

JUNE 9, 2022

Today’s guest post comes from Edward Hensley, Co-founder and Chief Commercial Officer at AssistRx. Edward offers five ways life sciences companies can use technology to transform their patient support services and thus differentiate their products. To learn more, sign up for AssistRx’s free webinar Specialty Pharma’s 2022 Patient Support Trends: Progress Check.

79

79

pharmaphorum

JUNE 10, 2022

Pharma’s evolving role in patient care. The digital revolution has already reshaped the commercial engine of biopharma companies. Pharma’s digital initiatives now routinely enable new channels that educate and market to patients, physician engagement that is more efficient and effective, and novel payment mechanisms and distribution models that improve access to therapies.

125

125

Outsourcing Pharma

JUNE 8, 2022

An expert from Rockwell Automation explains how integrating flexibility, using advanced technology, can help pharma manufacturing operations weather a storm.

75

75

Pharma Times

JUNE 6, 2022

New facility opens on the Cambridge Research Park offering pharmaceutical development services

Drug Development 126

Drug Development 126

NY Times

JUNE 7, 2022

El estudio era pequeño y los expertos dicen que hay que replicarlo. Pero para 18 pacientes oncológicos, el resultado produjo “lágrimas de felicidad”.

68

68

pharmaphorum

JUNE 6, 2022

Shares in Praxis Precision Medicines were in freefall today after the company’s efforts to develop a new therapy for major depressive disorder (MDD) ended in failure, forcing a restructuring and staff cuts. The selloff followed the announcement of the phase 2/3 Aria study results with PRAX-114 as a monotherapy for MDD, which showed the GABA positive allosteric modulator was unable to show a significant benefit on any of the study’s primary and secondary endpoints.

109

109

Outsourcing Pharma

JUNE 6, 2022

Efanesoctocog alfa is an investigational factor III therapy designed to prevent bleeds and bleeding episodes in patients diagnosed with the rare disorder.

71

71

Pharma Times

JUNE 7, 2022

New data now reveals significant increases in the blood glucose time-in-range compared to baseline, following VX-880 dosage

Dosage 109

Dosage 109

Pharmaceutical Commerce

JUNE 10, 2022

A conversation with EY life sciences leaders Jim Welch and Jay Welsh.

87

87

pharmaphorum

JUNE 9, 2022

Sanofi has launched a new initiative in its drive to integrate digital technologies throughout its business, setting up an accelerator based in Paris that will serve as the lynchpin of the effort. The accelerator has been set up to “develop products and solutions that will support Sanofi’s mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI)”, said the drugmaker.

103

103

Outsourcing Pharma

JUNE 6, 2022

Coming back to the real world June 13-16, the industry event will offer face-to-face learning, networking opportunities, and fun, star-studded opportunities.

59

59

Pharma Times

JUNE 8, 2022

The company received the Innovation Passport in the UK for zilebesiran, an investigational treatment of hypertension

108

108

Viseven

JUNE 10, 2022

There are tasks we, humans, can perform well with our eyes closed. Managing a successful multichannel customer engagement strategy is not on that list. Not seeing your output is about the second worst thing if you are a marketer, brand or product manager (after producing no output). In life sciences, that field of extra responsible decision making, detailed insights after each step are, of course, an especially prized possession.

Communication 52

Communication 52

pharmaphorum

JUNE 6, 2022

Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. The addition to the company’s portfolio – which already spans services like patient support, digital engagement, dispensing and distribution, and data/analytics – has arrived on the back of an alliance with business and wellness coaching specialist Limitless Minds.

101

101

Drug Patent Watch

JUNE 9, 2022

Annual Drug Patent Expirations for ZYRTEC-D+12+HOUR Zyrtec-d 12 Hour is a drug marketed by J And J Consumer Inc and is included in one NDA. It is available from one…. The post New patent expiration for J And drug ZYRTEC-D 12 HOUR appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

JUNE 9, 2022

Vital dengue vaccine offers over four years’ protection following successful clinical trial

Vaccines 115

Vaccines 115

Flip the Pharmacy

JUNE 9, 2022

Emily Wicker, PharmD PGY-1 Community-Based Pharmacy Resident The Ohio State University and Uptown Pharmacy While pharmacies have been providing vaccines for years, the Covid-19 pandemic has highlighted the accessibility of vaccines in community pharmacies and the role of pharmacists in strengthening vaccine confidence in our patients and communities.

Vaccines 52

Vaccines Community Pharmacies Immunity Immunization 52

pharmaphorum

JUNE 6, 2022

In February, AstraZeneca and Daiichi Sankyo teased the results of their pivotal trial of Enhertu in HER2-low breast cancer, and, at ASCO, they finally revealed the data – with the numbers every bit as good as hoped. The top-line results of DESTINY Breast-04 are impressive – in patients with HER2-low metastatic breast cancer who received multiple lines of prior treatment, Enhertu (trastuzumab deruxtecan) reduced the risk of disease progression or death by 49%, whilst improving overall survi

Chemotherapy 100

Chemotherapy 100

Drug Patent Watch

JUNE 9, 2022

Annual Drug Patent Expirations for ALTRENO Altreno is a drug marketed by Dow Pharm and is included in one NDA. It is available from one supplier. There is one patent…. The post New patent for Dow Pharm drug ALTRENO appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

JUNE 7, 2022

The agreement will see the two companies expand current oligonucleotide technologies

120

120

Pharma Mirror

JUNE 8, 2022

Shanghai/Amsterdam: CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index [1] – an annual score of each country’s pharma industry strength – with its overall score rising by 7.2%, the largest increase of any nation.

52

52

pharmaphorum

JUNE 10, 2022

Babies born to mothers who contracted COVID-19 during seem to be at slightly higher risk of neurodevelopmental delays, say US researchers, although they caution their findings are preliminary. Their retrospective study looked at more than 7,500 infants delivered during the pandemic, including 222 born to mothers with a positive COVID-19 test during pregnancy.

Medical Schools 99

Medical Schools Diabetes Hospitals 99

Drug Patent Watch

JUNE 9, 2022

Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are eighteen patents…. The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

JUNE 9, 2022

Agreement between the two companies includes process development of AAV-based gene therapies

100

100

Pharma Mirror

JUNE 8, 2022

SYDNEY, Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 “Accelerating clinical development in China and the US” Register here [link] JUNE 711:00am – 11:45am ET (1:00 – 1:45 local time)Novotech Booth at ASCO #14115 The virtual session will cover the latest on the clinical trial landscape and infrastructure in China and includes Novotech’s DCT partner, Obvio Health, on DC

52

52